Perception of Darbepoetin Subcutaneous Delivery Systems

Phase 4

Active, not recruiting

• Conditions: Pain perception of injectable medication; Chronic kidney disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12611000839909
• Lead Sponsor: Health Department of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients with chronic kidney disease already maintained on darbepoetin injections and deemed capable of device training and completion of a questionnaire

Exclusion Criteria

Patients who are unable to self-administer subcutaneously, unable to be trained on administration technique or incapable of giving informed consent will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified